» Articles » PMID: 33584645

Neutrophil Extracellular Traps Tied to Rheumatoid Arthritis: Points to Ponder

Overview
Journal Front Immunol
Date 2021 Feb 15
PMID 33584645
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, neutrophil extracellular traps at the forefront of neutrophil biology have proven to help capture and kill pathogens involved in the inflammatory process. There is growing evidence that persistent neutrophil extracellular traps drive the pathogenesis of autoimmune diseases. In this paper, we summarize the potential of neutrophil extracellular traps to drive the pathogenesis of rheumatoid arthritis and experimental animal models. We also describe the diagnosis and treatment of rheumatoid arthritis in association with neutrophil extracellular traps.

Citing Articles

NETosis: A key player in autoimmunity, COVID-19, and long COVID.

Monsalve D, Acosta-Ampudia Y, Acosta N, Celis-Andrade M, Sahin A, Yilmaz A J Transl Autoimmun. 2025; 10:100280.

PMID: 40071133 PMC: 11894324. DOI: 10.1016/j.jtauto.2025.100280.


VSTM1/SIRL-1: An Inhibitory Pattern Recognition Receptor Regulating Myeloid Cells.

Koops M, Meyaard L Eur J Immunol. 2025; 55(2):e202451465.

PMID: 39989259 PMC: 11848704. DOI: 10.1002/eji.202451465.


Circulating cell-free DNA as a potential biomarker for prediction of disease activity and prognosis among Egyptian rheumatoid arthritis patients.

Taha S, Samaan S, Hawash S, El-Sehsah E, Shamloul S, Elsheikh D Int J Immunopathol Pharmacol. 2025; 39:3946320251315036.

PMID: 39891356 PMC: 11786270. DOI: 10.1177/03946320251315036.


-induced NETs are highly cytotoxic on hepatic and colonic cells due to serine proteases and myeloperoxidase activities.

Jorge-Rosas F, Diaz-Godinez C, Garcia-Aguirre S, Martinez-Calvillo S, Carrero J Front Immunol. 2024; 15:1493946.

PMID: 39687618 PMC: 11646992. DOI: 10.3389/fimmu.2024.1493946.


Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides.

Haro I, Castellanos-Moreira R, Sanmarti R, Gomara M Diagnostics (Basel). 2024; 14(22).

PMID: 39594151 PMC: 11593125. DOI: 10.3390/diagnostics14222485.


References
1.
Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

2.
Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, Fujio K . Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci Rep. 2015; 5:13041. PMC: 4544002. DOI: 10.1038/srep13041. View

3.
Rohrbach A, Hemmers S, Arandjelovic S, Corr M, Mowen K . PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis. Arthritis Res Ther. 2012; 14(3):R104. PMC: 3446481. DOI: 10.1186/ar3829. View

4.
Li P, Li M, Lindberg M, Kennett M, Xiong N, Wang Y . PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010; 207(9):1853-62. PMC: 2931169. DOI: 10.1084/jem.20100239. View

5.
Klareskog L, Lundberg K, Malmstrom V . Autoimmunity in rheumatoid arthritis: citrulline immunity and beyond. Adv Immunol. 2013; 118:129-58. DOI: 10.1016/B978-0-12-407708-9.00003-0. View